Douglas S. Scherr

42.1k total citations · 1 hit paper
432 papers, 11.4k citations indexed

About

Douglas S. Scherr is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Douglas S. Scherr has authored 432 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Surgery, 147 papers in Cardiology and Cardiovascular Medicine and 119 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Douglas S. Scherr's work include Bladder and Urothelial Cancer Treatments (138 papers), Urinary and Genital Oncology Studies (91 papers) and Cardiac Arrhythmias and Treatments (91 papers). Douglas S. Scherr is often cited by papers focused on Bladder and Urothelial Cancer Treatments (138 papers), Urinary and Genital Oncology Studies (91 papers) and Cardiac Arrhythmias and Treatments (91 papers). Douglas S. Scherr collaborates with scholars based in United States, Austria and France. Douglas S. Scherr's co-authors include Shahrokh F. Shariat, Jay D. Raman, Pierre I. Karakiewicz, Yair Lotan, Casey K. Ng, Évanguelos Xylinas, Stephen A. Boorjian, Hugh Calkins, Darshan Dalal and David Spragg and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Douglas S. Scherr

401 papers receiving 11.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective

2024 83 citations Douglas S. Scherr et al. EP Europace profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas S. Scherr United States	57	5.2k	2.9k	2.6k	1.9k	1.8k	432	11.4k
Nancy L. Geller United States	61	4.9k 0.9×	2.1k 0.7×	1.6k 0.6×	1.4k 0.7×	268 0.1×	220	11.5k
James O. Peabody United States	46	3.6k 0.7×	551 0.2×	4.1k 1.6×	806 0.4×	1.6k 0.8×	209	7.6k
Kathleen J. Propert United States	50	1.8k 0.4×	543 0.2×	2.6k 1.0×	1.7k 0.9×	2.0k 1.1×	147	9.9k
Elyn Riedel United States	55	3.3k 0.6×	1.1k 0.4×	4.0k 1.5×	1.4k 0.7×	229 0.1×	155	10.4k
Giacomo Novara Italy	69	8.6k 1.6×	530 0.2×	9.1k 3.5×	2.1k 1.1×	5.8k 3.1×	323	17.1k
Amit Gupta India	43	2.9k 0.5×	494 0.2×	1.8k 0.7×	530 0.3×	1.1k 0.6×	333	5.9k
Mark F. Munsell United States	64	2.8k 0.5×	539 0.2×	2.2k 0.8×	2.0k 1.1×	507 0.3×	243	11.8k
Michael O. Koch United States	54	3.3k 0.6×	265 0.1×	3.1k 1.2×	1.5k 0.8×	1.7k 0.9×	280	8.3k
James W.F. Catto United Kingdom	64	8.5k 1.6×	387 0.1×	4.4k 1.7×	4.7k 2.5×	2.4k 1.3×	295	15.8k
Ganesh V. Raj United States	53	3.2k 0.6×	274 0.1×	5.8k 2.2×	4.0k 2.2×	1.5k 0.8×	195	11.5k

Countries citing papers authored by Douglas S. Scherr

Since Specialization

Citations

This map shows the geographic impact of Douglas S. Scherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Scherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Scherr more than expected).

Fields of papers citing papers by Douglas S. Scherr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas S. Scherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Scherr. The network helps show where Douglas S. Scherr may publish in the future.

Co-authorship network of co-authors of Douglas S. Scherr

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Scherr. A scholar is included among the top collaborators of Douglas S. Scherr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Scherr. Douglas S. Scherr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manninger, Martin, Astrid N L Hermans, Jonas L. Isaksen, et al.. (2025). Machine-learning guided differentiation between photoplethysmography waveforms of supraventricular and ventricular origin. Computer Methods and Programs in Biomedicine. 267. 108798–108798.

Traykov, Vassil, Helmut Pürerfellner, Haran Burri, et al.. (2025). EHRA perspective on the digital data revolution in arrhythmia management: insights from the association’s annual summit. EP Europace. 27(8). 2 indexed citations

Rohrer, Ursula, et al.. (2024). Substrate modification via epicardial ablation in a patient with long QT syndrome type II. HeartRhythm Case Reports. 10(8). 568–571. 1 indexed citations

Duytschaever, Mattias, Gediminas Račkauskas, Tom De Potter, et al.. (2024). Dual energy for pulmonary vein isolation using dual-energy focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 3-month results. EP Europace. 26(5). 18 indexed citations

Benedikt, Martin, Faisal Aziz, Ewald Kolesnik, et al.. (2024). Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin. Scientific Reports. 14(1). 15083–15083. 1 indexed citations

Scherr, Douglas S., et al.. (2024). Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation. EP Europace. 27(1). 6 indexed citations

Barbieri, Fabian, Bernhard Pfeifer, Thomas Senoner, et al.. (2024). A Neuronal Network-Based Score Predicting Survival in Patients Undergoing Aortic Valve Intervention: The ABC-AS Score. Journal of Clinical Medicine. 13(13). 3691–3691. 4 indexed citations

Manninger, Martin, et al.. (2023). Prolonged asystole after conversion to sinus rhythm during pulmonary vein isolation with pulsed field ablation: A case report. HeartRhythm Case Reports. 10(2). 146–150.

Demolder, Anthony, Louisa O’Neill, Milad El Haddad, et al.. (2023). No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial. Circulation Arrhythmia and Electrophysiology. 16(11). e012043–e012043. 4 indexed citations

10.

Vlachostergios, Panagiotis J., Muhammad Junaid Niaz, Charlene Thomas, et al.. (2022). Pilot study of the diagnostic utility of ⁸⁹Zr‐df‐IAB2M and ⁶⁸Ga‐PSMA‐11 PET imaging and multiparametric MRI in localized prostate cancer. The Prostate. 82(4). 483–492. 13 indexed citations

11.

Schuettfort, Victor M., Benjamin Pradère, Quoc‐Dien Trinh, et al.. (2021). Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer. Cancer Immunology Immunotherapy. 71(1). 85–95. 13 indexed citations

12.

Kneihsl, Markus, Thomas Gattringer, Egbert Bisping, et al.. (2019). Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation–Related Stroke. Stroke. 50(8). 2223–2226. 22 indexed citations

13.

Manninger, Martin, et al.. (2019). T2 and T2∗ mapping in ex situ porcine myocardium: myocardial intravariability, temporal stability and the effects of complete coronary occlusion. International Journal of Legal Medicine. 134(2). 679–690. 1 indexed citations

14.

Ayangbesan, Abimbola, David Golombos, Ron Golan, et al.. (2018). Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses. Journal of Endourology. 33(1). 50–60. 2 indexed citations

15.

Taylor, Benjamin, Ariana L. Smith, Abimbola Ayangbesan, et al.. (2018). Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?. Clinical Genitourinary Cancer. 17(1). e209–e215. 11 indexed citations

16.

Shoag, Jonathan E., Paul J. Christos, Sameer Mittal, et al.. (2017). Vasectomy and Risk of Prostate Cancer in a Screening Trial. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1653–1659. 10 indexed citations

17.

Zweiker, David, Johannes Schmid, Martin Manninger, et al.. (2017). Atrial fibrillation in transcatheter aortic valve implantation patients: Incidence, outcome and predictors of new onset. Journal of Electrocardiology. 50(4). 402–409. 12 indexed citations

18.

Green, David A., M. Durand, Naveen Gumpeni, et al.. (2012). Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. British Journal of Urology. 110(10). 1463–1470. 38 indexed citations

19.

Sooriakumaran, Prasanna, Majnu John, Paul J. Christos, et al.. (2011). Models to Predict Positive Prostate Biopsies Using the Tyrol Screening Study. Urology. 78(4). 924–929. 4 indexed citations

20.

Wonisch, Manfred, Peter Hofmann, Ronald Hödl, et al.. (2003). Spiroergometrie in der Kardiologie - Klinische Anwendungsmöglichkeiten. Journal für Kardiologie (Krause & Pachernegg GmbH). 10(10). 440–446. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact